GEO-PHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GEO-PHARM
Largest movements
- Receivables within one year -€79,034
down €79,034 (-42.8%), from €184,619 to €105,585
of which Trade receivables: -€57,299
- Cash +€58,565
up €58,565 (+280%), from €20,906 to €79,471
mainly Receivables within one year (+€79,034) and Net result for the year (+€59,343)
- Financial fixed assets +€29,980
up €29,980 (+13.4%), from €224,241 to €254,221
- Current investments +€17,304
new in 2025: €17,304
- Tangible fixed assets -€6,042
down €6,042 (-12.6%), from €47,803 to €41,762
of which Other tangible fixed assets: -€4,648
- Reserves +€59,343
up €59,343 (+47.5%), from €124,815 to €184,158
- Tax, wage and social debts -€24,994
down €24,994 (-63.0%), from €39,697 to €14,703
- Trade debts -€14,533
down €14,533 (-82.1%), from €17,698 to €3,165
- Gross operating margin -€83,062
down €83,062 (-41.4%), from €200,683 to €117,621
- Taxes -€21,060
down €21,060 (-32.7%), from €64,461 to €43,401
- Financial charges +€2,702
up €2,702 (+232%), from €1,163 to €3,866
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €479,212 | €499,024 | +€19,812 | +4.1% |
| Fixed assets | 21/28 | €272,044 | €295,983 | +€23,938 | +8.8% |
| Tangible fixed assets | 22/27 | €47,803 | €41,762 | -€6,042 | -12.6% |
| Plant, machinery and equipment | 23 | €1,115 | €2,046 | +€931 | +83.5% |
| Furniture and vehicles | 24 | €9,758 | €7,434 | -€2,324 | -23.8% |
| Other tangible fixed assets | 26 | €36,930 | €32,282 | -€4,648 | -12.6% |
| Financial fixed assets | 28 | €224,241 | €254,221 | +€29,980 | +13.4% |
| Current assets | 29/58 | €207,167 | €203,041 | -€4,126 | -2.0% |
| Amounts receivable within one year | 40/41 | €184,619 | €105,585 | -€79,034 | -42.8% |
| Trade receivables | 40 | €145,356 | €88,057 | -€57,299 | -39.4% |
| Other amounts receivable | 41 | €39,264 | €17,528 | -€21,736 | -55.4% |
| Current investments | 50/53 | - | €17,304 | +€17,304 | |
| Cash at bank and in hand | 54/58 | €20,906 | €79,471 | +€58,565 | +280% |
| Deferred charges and accrued income | 490/1 | €1,642 | €682 | -€960 | -58.5% |
| Total equity and liabilities | 10/49 | €479,212 | €499,024 | +€19,812 | +4.1% |
| Equity | 10/15 | €418,417 | €477,760 | +€59,343 | +14.2% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €124,815 | €184,158 | +€59,343 | +47.5% |
| Distributable reserves | 133 | €124,815 | €184,158 | +€59,343 | +47.5% |
| Profit (loss) carried forward | 14 | €287,402 | €287,402 | = | 0.0% |
| Amounts payable | 17/49 | €60,794 | €21,264 | -€39,530 | -65.0% |
| Amounts payable within one year | 42/48 | €60,794 | €21,264 | -€39,530 | -65.0% |
| Current portion of amounts payable after more than one year | 42 | €3,399 | €3,396 | -€3 | -0.1% |
| Trade debts | 44 | €17,698 | €3,165 | -€14,533 | -82.1% |
| Suppliers | 440/4 | €17,698 | €3,165 | -€14,533 | -82.1% |
| Taxes, remuneration and social security | 45 | €39,697 | €14,703 | -€24,994 | -63.0% |
| Taxes | 450/3 | €39,697 | €14,703 | -€24,994 | -63.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,145 | €9,737 | +€592 | +6.5% |
| Other operating charges | 640/8 | €1,099 | €1,279 | +€180 | +16.3% |
| Gross operating margin | 9900 | €200,683 | €117,621 | -€83,062 | -41.4% |
| Operating profit (loss) | 9901 | €190,439 | €106,605 | -€83,834 | -44.0% |
| Financial income | 75/76B | €1 | €5 | +€4 | +782% |
| Recurring financial income | 75 | €1 | €5 | +€4 | +782% |
| Financial charges | 65/66B | €1,163 | €3,866 | +€2,702 | +232% |
| Recurring financial charges | 65 | €1,163 | €3,866 | +€2,702 | +232% |
| Profit (loss) for the period before taxes | 9903 | €189,276 | €102,744 | -€86,532 | -45.7% |
| Income taxes | 67/77 | €64,461 | €43,401 | -€21,060 | -32.7% |
| Profit (loss) for the period | 9904 | €124,815 | €59,343 | -€65,473 | -52.5% |
| Profit (loss) for the period to be appropriated | 9905 | €124,815 | €59,343 | -€65,473 | -52.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.